GovChime
Notice ID: f8a195de2820434887d41c968c9777baAward NoticeAwarded

6640--EQUIPMENT, Odyssey XF Imaging Bundle, Detroit

Awarded on July 28, 2026. Full description on SAM.gov.

Awarded tounder 36C25026P0915 (source: SAM.gov award notice)• $39.2K

Overview

Posted
July 28, 2026
Notice type
Award Notice
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov
Award date
Jul 28, 2026
Award amount (SAM.gov award notice)
$39.2K

Identifiers

Solicitation number
36C25026Q0719
Notice ID
f8a195de2820434887d41c968c9777ba
Award number (PIID)
36C25026P0915

Description

Notice of Intent to Sole Source Requirement The Department of Veterans Affairs, VISN 10 John D. Dingell Detroit VA Medical Center, intends to negotiate a Sole Source award under RFO 12. Description of equipment requirements: Odyssey® XF Imaging Bundle System Qty. Part Number Description 1 2802-03 Odyssey XF Imaging Bundle-Standard The associated NAICS code is 334514 The sole source contract will be awarded to: Li-Cor, Inc. d/b/a Li-Cor Biosciences 4647 Superior St. Lincoln, NE 68504 USA. LI-COR BIOTECH, LLC, is needed because they can provide the exact item, installation, and service support as needed. A firm fixed-price contract with no option years is anticipated and shall be awarded. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. The Government intends to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. It is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Responses must be received no later than 4:00 p.m. (EST), July 16, 2026. Natalie Harris Contract Specialist natalie.harris4@va.gov

Full description on SAM.gov

Award Overview

Award Number

36C25026P0915

Award Amount (SAM.gov award notice)

$39.2K

Award Date

Jul 28, 2026

Awardee

Awardee UEI

TNDWGEPWZLK8

Awardee CAGE Code

9R8Y0

Awardee Address

LINCOLN, NE 68504, NE

Original Solicitation

Notice ID: f8a195de2820434887d41c968c9777ba

Posted Date: Jul 28, 2026

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

1
  • 36C26225P2282
    LI-COR BIOTECH, LLC
    Department of Veterans AffairsNAICS 334516
    $53.3KSigned Sep 26, 2025

Contacts

Contracting Officer

Primary Contact

Natalie Harris
Contract Specialist

Documents

Files (2)

  • 36C25026P0915_1.docx

    13 KBAdded in Award Notice version 2Posted
    Download
  • 36C25026Q0719.docx

    25 KBAdded in Special Notice version 4Posted
    Download

Lifecycle

  1. 4
    Version 4Special NoticeArchived

    6640--EQUIPMENT, Odyssey XF Imaging Bundle, Detroit

    Notice fb5581e0200748a98d61bb4268a6b36e on SAM.gov

  2. 2
    Version 2Award NoticeCurrent

    Type changed from Special Notice to Award Notice

    6640--EQUIPMENT, Odyssey XF Imaging Bundle, Detroit

    Notice f8a195de2820434887d41c968c9777ba on SAM.gov

Other notices for this solicitation

  1. Special NoticeRelated noticeJul 9, 2026

    6640--EQUIPMENT, Odyssey XF Imaging Bundle, Detroit

    Notice 1a22e57c6bb74f3fbde6070a919d8298 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
INTENT TO SOLE SOURCE AND JUSTIFICATION
73%
Special Notice08/24/2026
1. Disclaimer THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice is issued solely for information and market research planning purposes. It does not constitute a Request for Quotation (RFQ), Request for Proposal (RFP), or Invitation for Bids (IFB), nor does it restrict the Government to a particular acquisition approach. No contract or purchase order will be awarded from this announcement, and the Government will not reimburse respondents for any costs incurred in preparing a response. 2. Background and Purpose The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions,, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Section of Cell Cycle Regulation, has a requirement for a Brand-Name Lonza 4D-Nucleofector® System consisting of the following: 4D-Nucleofector Core Unit, Part No. AAF-1003B – Quantity (1) EA 4D-Nucleofector X Unit, Part No. AAF-1003X - Quantity (1) EA 3. One-year warranty extension for each unit. Or a functional domestic equivalent, to support ongoing NIH-funded research involving the genetic manipulation of mammalian cells. Because NICHD's ongoing studies rely on previously validated electroporation pulse-code workflows, experimental protocols, and Nucleocuvette™ consumables established on a prior-generation Lonza Nucleofector platform, the Lonza 4D-Nucleofector® System is the primary known platform capable of ensuring experimental reproducibility and data continuity without requiring costly and time-consuming protocol re-optimization or re-validation. The Office of Acquisitions is conducting market research to identify qualified vendors—including small businesses, authorized distributors, and domestic manufacturers—and specifically seeks market information to determine: 1. Authorized Lonza Sources: The availability of Lonza Walkersville, Inc. or authorized distributors/resellers (including small businesses, HUBZone, 8(a), SDVOSB, WOSB, and Small Disadvantaged Businesses under NAICS 334516) capable of supplying new Lonza equipment with full manufacturer-backed warranties. 2. Buy American Act (FAR Part 25) Compliance: The availability of any domestic end products manufactured in the United States capable of meeting all functional, warranty, training, and legacy workflow-continuity requirements outlined in Section 3 without requiring experimental re-validation. 3. Technical Requirements and Salient Characteristics To meet the Government's minimum requirements, the proposed system must satisfy all functional and technical specifications from the Statement of Work alongside the laboratory's workflow-continuity constraints: Core Control Unit: The system shall include a Lonza 4D-Nucleofector® Core Unit (or a domestic equivalent central control unit) capable of controlling and operating advanced electroporation-based transfection protocols. Small-Volume Transfection Module: The system shall include a Lonza 4D-Nucleofector® X Unit (or a domestic equivalent functional module) capable of processing small-volume samples (specifically ranging from 20 µL to 100 µL) and supporting transfection of primary cells and other difficult-to-transfect cell types. Nucleic Acid & Reagent Delivery: The system shall support delivery of plasmid DNA, RNA, siRNA, CRISPR/Cas9 reagents, and other nucleic acid-based materials into mammalian cells. Optimized Transfection Performance: The system shall provide optimized electroporation programs designed to maximize transfection efficiency while maintaining high post-transfection cell viability. Sensitive Cell Applications: The system shall support research applications involving primary cells, stem cells, immune cells, and other sensitive cell populations that are not efficiently transfected using conventional lipid-based methods. Software and Protocols: The system shall include manufacturer-provided software and protocols necessary for operation of the instrument. Warranty Coverage: The system shall include a minimum one-year manufacturer warranty and one-year warranty extension coverage for both the Core Unit and X Unit (two years total coverage). Warranty coverage shall begin upon Government acceptance of the equipment and continue in accordance with the manufacturer's warranty terms. Consumable & Legacy Protocol Continuity: If proposing Lonza equipment, the system shall be 100% compatible with commercially available Lonza Nucleofector® reagents, Nucleocuvette™ consumables, and existing pulse-code workflows previously developed and validated on a prior-generation Lonza Nucleofector platform. If proposing a domestic alternative, the vendor must demonstrate that its system and consumables achieve equivalent transfection efficiency and post-transfection cell viability across NICHD's existing mammalian cell workflows without requiring protocol re-optimization or experimental re-validation. Delivery, Installation, and Training: Equipment must be delivered to NIH Bethesda (Building 49) and installed, with on-site or virtual user training for up to five (5) NIH personnel completed within 30 days of installation (covering system operation, software functionality, routine maintenance, and basic troubleshooting). All delivery, installation, and training shall be completed within the 12-month period of performance from award. 4. Capability Statement Submission Instructions Interested organizations that believe they can meet all requirements outlined in Section 3 are invited to submit a tailored Capability Statement (no more than 5 pages) containing the following information: 1. Company Profile: Organization name, mailing address, primary Point of Contact (name, title, email, and telephone number), SAM.gov Unique Entity ID (UEI), and CAGE code. 2. Business Size & Socioeconomic Status: Business size under NAICS 334516 (1,000-employee size standard) and applicable socioeconomic designations (e.g., Small Business, Woman-Owned, Veteran-Owned, Service-Disabled Veteran-Owned, HUBZone, 8(a)). 3. Contract Vehicles: Identification of any existing federal contract vehicles held by the vendor through which this equipment can be ordered (e.g., GSA Multiple Award Schedule), or confirmation of open-market availability. 4. Country of Origin (COO): Explicit identification of the manufacturing country of origin for all proposed hardware components and confirmation of whether the system qualifies as a domestic end product under the Buy American Act (FAR Part 25). 5. Technical Capability & Authorization: Product brochures, technical specifications, and catalog numbers demonstrating compliance with every requirement in Section 3. If proposing Lonza equipment: Documentation confirming status as an Authorized Distributor/Reseller eligible to provide new equipment and manufacturer-backed warranties. If proposing a domestic alternative: Technical evidence proving equivalent transfection performance and workflow continuity with existing NICHD mammalian cell protocols without requiring experimental re-validation. 6. Rough Order of Magnitude (ROM) Pricing (Optional): Non-binding budgetary pricing estimate for market research purposes. 5. Place of Performance: NIH, 9000 Rockville Pike, Bethesda, MD 20892 6. Submission Deadline and Contact Information Please submit electronic Capability Statements in PDF or Microsoft Word format via email to Tina Robinson at robinsti@mail.nih.gov no later than November 18, 2026, at 11:00 AM EST. Telephone inquiries will not be accepted. Capability Statements must reference Notice Number 75N98027R00019. Email submissions and any questions must be sent to robinsti@mail.nih.gov and include Notice Number 75N98027R00019 in the subject line. Capability Statements and attachments will not be returned to the sender. This synopsis is for information and planning purposes only and shall not be construed as a commitment by the Government, nor will the Government pay for information solicited.
70%
Market Research11/18/2026
6640 - Purchase of (1) Millipore Sigma Milli-Q HX 7080 and (3) Millipore Sigma Milli-Q IQ 7005 water purification systems for the Region 2 Laboratory
69%
Solicitation11/09/2026
Nitrogen Content Analysis Equipment: Amendment 0001: 1. Which nitrogen analysis instrument does the laboratory operate today? - Nitrogen determination divides into Kjeldahl and Dumas combustion methods, and the two are not interchangeable with an existing accredited method.The nitrogen analysis is performed using a ferrous sulphate potentiometric titration method. The needed equipment was specified in the solicitation.2. Which method is required here, and is there a required make and model, or will an equal meeting stated salient characteristics be considered? If salient characteristics have been documented, please confirm where they are posted.- Method 4.5.1.2 of MIL-N-00494B and 4.5.1 of MIL-DTL-244C Amendment 1; both publicly available documents. 3. Sample matrix and required throughput.N/A see method4. Scope: is an autosampler, digestion unit, scrubber or fume handling included? Are consumables and reference standards included?No5. Are installation, operational qualification and operator training within contractor scope?This was detailed in the solicitation. 6. Required warranty term and whether a service or calibration plan is in scope.This was detailed in the solicitation. 7. Required delivery date.This was detailed in the solicitation. Amendment 0002: added Brand Name Solicitation
69%
Combined Synopsis10/29/2026
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and separate written solicitation will not be issued. Solicitation number 12444027Q0008 is issued as a Request for Quotation (RFQ) for Seed Lab Equipment for the Southern Region. This acquisition is not set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 334516. This acquisition is an unrestricted requirement. All responsible sources may submit a quotation which will be considered by the agency. Quotes are due on 11/19/2026, 5pm EST. Email quotes to john.camacho@usda.gov
68%
Combined Synopsis11/19/2026

Additional Details

Solicitation Number

36C25026Q0719

Archive Date

Nov 4, 2026

Office Address

DAYTON, OH, 45428